Literature DB >> 22135258

Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.

M Espasa1, M Salvadó, E Vicente, G Tudó, F Alcaide, P Coll, N Martin-Casabona, M Torra, D Fontanals, J González-Martín.   

Abstract

The aim of this study was to evaluate the reliability of the VersaTREK system for Mycobacterium tuberculosis drug susceptibility testing compared with results obtained with the Bactec MGIT 960 system. A total of 67 strains were evaluated. Overall agreement was at 98.5%. Kappa indexes were 1.0 for isoniazid, rifampin, and ethambutol, 0.937 for pyrazinamide, and 0.907 for streptomycin. The VersaTREK system is validated for M. tuberculosis drug susceptibility testing.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22135258      PMCID： PMC3264154          DOI： 10.1128/JCM.06432-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method.

Authors:  P Ruiz; F J Zerolo; M J Casal
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide.

Authors:  Vincent J LaBombardi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion.

Authors:  Enrico Tortoli; Marta Benedetti; Alessandra Fontanelli; M Tullia Simonetti
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  F Ardito; B Posteraro; M Sanguinetti; S Zanetti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update.

Authors:  D Falzon; E Jaramillo; H J Schünemann; M Arentz; M Bauer; J Bayona; L Blanc; J A Caminero; C L Daley; C Duncombe; C Fitzpatrick; A Gebhard; H Getahun; M Henkens; T H Holtz; J Keravec; S Keshavjee; A J Khan; R Kulier; V Leimane; C Lienhardt; C Lu; A Mariandyshev; G B Migliori; F Mirzayev; C D Mitnick; P Nunn; G Nwagboniwe; O Oxlade; D Palmero; P Pavlinac; M I Quelapio; M C Raviglione; M L Rich; S Royce; S Rüsch-Gerdes; A Salakaia; R Sarin; D Sculier; F Varaine; M Vitoria; J L Walson; F Wares; K Weyer; R A White; M Zignol
Journal:  Eur Respir J       Date:  2011-08-04       Impact factor: 16.671

6.  Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis.

Authors:  Pascale Bemer; Frantiska Palicova; Sabine Rüsch-Gerdes; Henri B Drugeon; Gaby E Pfyffer
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

7.  Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.

Authors:  A Laszlo; M Rahman; M Espinal; M Raviglione
Journal:  Int J Tuberc Lung Dis       Date:  2002-09       Impact factor: 2.373

8.  Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method.

Authors:  Claudio Scarparo; Paolo Ricordi; Giuliana Ruggiero; Paola Piccoli
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens.

Authors:  G D Roberts; N L Goodman; L Heifets; H W Larsh; T H Lindner; J K McClatchy; M R McGinnis; S H Siddiqi; P Wright
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

10.  Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis.

Authors:  J J Tarrand; D H Gröschel
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948
View more
  7 in total

Review 1.  Improved Conventional and New Approaches in the Diagnosis of Tuberculosis.

Authors:  Baoyu Dong; Zhiqun He; Yuqing Li; Xinyue Xu; Chuan Wang; Jumei Zeng
Journal:  Front Microbiol       Date:  2022-05-31       Impact factor: 6.064

2.  Molecular Characterization of Mycobacterium tuberculosis Strains with TB-SPRINT.

Authors:  Barbara Molina-Moya; Michel Kiréopori Gomgnimbou; Carmen Lafoz; Alicia Lacoma; Cristina Prat; Guislaine Refrégier; Sofia Samper; Jose Dominguez; Christophe Sola
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

3.  Performance of the BacT Alert 3D System Versus Solid Media for Recovery and Drug Susceptibility Testing of Mycobacterium tuberculosis in a Tertiary Hospital in Korea.

Authors:  Seoung-Cheol Kim; Bo-Young Jeon; Jin-Sook Kim; In Hwan Choi; Jiro Kim; Jeongim Woo; Soojin Kim; Hyeong Woo Lee; Monoldorova Sezim; Sang-Nae Cho
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-10-05

4.  GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun.

Authors:  Ming-Jin Zhang; Wen-Zhi Ren; Xue-Juan Sun; Yang Liu; Ke-Wei Liu; Zhong-Hao Ji; Wei Gao; Bao Yuan
Journal:  BMC Infect Dis       Date:  2018-05-22       Impact factor: 3.090

Review 5.  A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.

Authors:  Michael G Whitfield; Heidi M Soeters; Robin M Warren; Talita York; Samantha L Sampson; Elizabeth M Streicher; Paul D van Helden; Annelies van Rie
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

6.  Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China.

Authors:  Ping Zhao; Fang Fang; Qin Yu; Jiao Guo; Jian-Hua Zhang; Jifu Qu; Yingjie Liu
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

Review 7.  Tuberculosis in the Elderly.

Authors:  Pauline Caraux-Paz; Sylvain Diamantis; Benoit de Wazières; Sébastien Gallien
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.